A detailed history of Callahan Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Callahan Advisors, LLC holds 6,884 shares of ZTS stock, worth $1.13 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
6,884
Previous 6,578 4.65%
Holding current value
$1.13 Million
Previous $1.14 Million 17.89%
% of portfolio
0.14%
Previous 0.12%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$172.58 - $196.48 $52,809 - $60,122
306 Added 4.65%
6,884 $1.34 Million
Q2 2024

Jul 29, 2024

BUY
$145.54 - $178.83 $58,361 - $71,710
401 Added 6.49%
6,578 $1.14 Million
Q1 2024

Apr 24, 2024

SELL
$165.67 - $199.94 $22,199 - $26,791
-134 Reduced 2.12%
6,177 $1.05 Million
Q4 2023

Jan 24, 2024

BUY
$151.44 - $200.09 $3,483 - $4,602
23 Added 0.37%
6,311 $1.25 Million
Q3 2023

Oct 23, 2023

SELL
$167.14 - $192.77 $28,079 - $32,385
-168 Reduced 2.6%
6,288 $1.09 Million
Q2 2023

Jul 31, 2023

SELL
$160.94 - $186.23 $172,366 - $199,452
-1,071 Reduced 14.23%
6,456 $1.11 Million
Q1 2023

Apr 28, 2023

SELL
$145.48 - $175.02 $564,753 - $679,427
-3,882 Reduced 34.03%
7,527 $1.25 Million
Q4 2022

Feb 03, 2023

SELL
$131.14 - $157.47 $239,592 - $287,697
-1,827 Reduced 13.8%
11,409 $1.67 Million
Q3 2022

Oct 27, 2022

SELL
$148.29 - $182.55 $100,688 - $123,951
-679 Reduced 4.88%
13,236 $1.96 Million
Q2 2022

Jul 29, 2022

SELL
$155.97 - $200.09 $281,057 - $360,562
-1,802 Reduced 11.47%
13,915 $2.39 Million
Q1 2022

Apr 27, 2022

SELL
$181.39 - $234.03 $232,541 - $300,026
-1,282 Reduced 7.54%
15,717 $2.96 Million
Q4 2021

Feb 08, 2022

SELL
$193.69 - $247.03 $29,053 - $37,054
-150 Reduced 0.87%
16,999 $4.15 Million
Q3 2021

Nov 03, 2021

SELL
$189.29 - $209.69 $119,063 - $131,895
-629 Reduced 3.54%
17,149 $3.33 Million
Q2 2021

Aug 11, 2021

SELL
$155.9 - $187.99 $74,676 - $90,047
-479 Reduced 2.62%
17,778 $3.31 Million
Q1 2021

Apr 21, 2021

BUY
$144.0 - $169.39 $10,944 - $12,873
76 Added 0.42%
18,257 $2.88 Million
Q4 2020

Jan 20, 2021

SELL
$157.07 - $174.35 $40,366 - $44,807
-257 Reduced 1.39%
18,181 $3.01 Million
Q3 2020

Oct 26, 2020

BUY
$137.1 - $165.37 $99,397 - $119,893
725 Added 4.09%
18,438 $3.05 Million
Q2 2020

Jul 17, 2020

BUY
$111.92 - $142.53 $416,454 - $530,354
3,721 Added 26.59%
17,713 $2.43 Million
Q1 2020

Apr 06, 2020

BUY
$92.66 - $144.94 $76,073 - $118,995
821 Added 6.23%
13,992 $1.65 Million
Q4 2019

Jan 21, 2020

BUY
$116.25 - $133.25 $181,466 - $208,003
1,561 Added 13.45%
13,171 $1.74 Million
Q3 2019

Oct 21, 2019

BUY
$112.57 - $128.43 $580,861 - $662,698
5,160 Added 80.0%
11,610 $1.45 Million
Q2 2019

Jul 17, 2019

BUY
$97.98 - $114.28 $631,971 - $737,106
6,450 New
6,450 $732,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Callahan Advisors, LLC Portfolio

Follow Callahan Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callahan Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callahan Advisors, LLC with notifications on news.